Danone (DN) Barclays 18th Annual Global Consumer Staples Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Barclays 18th Annual Global Consumer Staples Conference 2025 summary
20 Oct, 2025Organizational transformation and leadership
Shifted to three macro-geographies to enhance agility and market impact, with a more compact executive committee and robust succession planning.
Recent executive departures addressed by a strong internal talent pool and succession plans.
Strategic growth and portfolio evolution
Transitioned from fixing fundamentals to focusing on science-driven, health-oriented growth, aiming to outpace industry growth rates.
Pivoting from a yogurt-centric image to expertise in protein and gut health, leveraging innovation like Oikos protein shakes.
Pruned portfolio for efficiency, now targeting both relative and absolute growth in sales and earnings.
Key product and category performance
Aptamil, a leading infant formula brand, is growing rapidly worldwide, with innovations like Essensis and Nuturis driving success, especially in China.
High protein products have grown from €300–400 million to over €1 billion, with significant expansion in the U.S. and other markets.
Coffee creamers faced supply chain issues but are recovering, with innovation and shelf space rebuilding underway.
Silk beverages in the U.S. remain a turnaround focus, with new initiatives planned.
Activia is shifting toward more differentiated, low-sugar, gut health-focused offerings, with innovations like Activia Proactive.
Latest events from Danone
- 4.5% LFL sales growth, margin up 44bps, and strong cash flow despite currency and recall impacts.DN
Q4 202520 Feb 2026 - Targets 3–5% sales growth, €3bn cash flow, and double-digit ROIC, led by health and protein focus.DN
CME 20243 Feb 2026 - 4.0% LFL sales growth, margin up, cash flow +11%, 2024 guidance confirmed.DN
Q2 20242 Feb 2026 - Q3 2024 like-for-like sales up 4.2%, with all regions and categories contributing to growth.DN
Q3 202419 Jan 2026 - Achieved 4.3% LFL sales growth, margin gains, and record €3.0bn free cash flow in FY 2024.DN
Q4 20247 Jan 2026 - Q1 2025 sales rose 4.3% LFL, led by strong growth in China and confirmed 2025 guidance.DN
Q1 202521 Dec 2025 - 4.2% LFL sales growth, margin up 49 bps, and strategic acquisitions highlight H1 2025.DN
Q2 20254 Nov 2025 - Q3 2025 sales rose 4.8% LFL, driven by volume/mix and strong China, North Asia & Oceania growth.DN
Q3 202528 Oct 2025